CBUS - Earnings call 3 2023

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon, and welcome to the Cibus Third Quarter 2023 Results Conference Call. [Operator Instructions] Please also note, today's event is being recorded.At this time, I'd like to turn the conference over to Wade King, Chief Financial Officer. Sir, please go ahead.

Wade King

Thank you, and good afternoon. This is Wade King, the Chief Financial Officer of Cibus. thank Third taking and Quarter Conference and to us to Corporate like Call Cibus' for XXXX Webcast. would you time for join Update I Financial Results and Executive Rory President on Co-Founder, Chief the and statements like regarding Operating the webcast, our is to Peter be future begin and and industry to results financial a those prospects call. today we of subject may call goals call, in from described number me Chairman; that forward-looking and and with those Co-Founder, to Presenting made Chief including could conference Officer Officer.Before uncertainties remind future are and differ results and Beetham, materially the that operational actual risks Riggs, I'd cause everyone filings list conference a to Please of SEC refer is call Cibus' risks.This webcast. being associated for webcast presentation corporate to like of analysis release would that, along are Relations Mr. with to I available of assist The our section press call over Investor your turn the in business.With cibus.com the and link the to on now Riggs. Go ahead, Rory.

Rory Riggs

where through welcome we Wade, and call. highlighting by I begin Then recent on walk commercial of everybody our will you Thanks I'll several business and Peter headed. the are and to we and are updates. where

business, with our finish its is goal of pipeline to of their a this will Wade of the and Lastly, format educational an provide discussion brief financials. overview The you prospects. with

going a better driving of from foundation business have and So recent discuss on R&D our our you're updates. of progress.With to company. that June like this been to company and an commercial understand I'd some to and in we equipped solid a to evolution our laser-focused Since that, commercial with company year, track events better public our

of on the bringing of this advancement our our focus launch now is centered initial to traits. operations our enhanced commercial at in a part aimed completing furthering goal, alignment commercial the resources transition, and our activities.All are which primary As October, of strategic underwent we of

these canola, X us strategic bolstering refocusing happens.So our necessary focus for Sclerotinia advancement canola Resistance rice, Tolerance our often that Herbicide strength top to priorities. Importantly, manner, our strategic #X our Pod on. with our I'll trait, in achieve realigned both objectives platform captured priorities Tolerance of realignment, And resources in let soybean.Notably, measures implemented hard objective and timely Shatter the as reduction PSR with HTX of and will well have Herbicide the Concurrent soybean our advancement more and also our in X cost working of model. Reduction HTX and the capital as the HTX traits, We developed have and traits. believe efforts some #X of business crop preserving as referred to that X advanced little in and our you to we these a of position progress we're X traits, me later a our development this speak traits make take well and to to sure on each

pipeline capabilities editing They our underway. well represents our of of centered market is opportunity this addressable major what million over just acres traits single-cell canola an applications our X XXX Combined, are efforts with canola, billion are the can potential and soybean. address.One in oligonucleotide-directed commercialization We this ultimately key that our rice, of believe advancing yet, accomplishments our of has beginning been believe of across started crop X soybeans. and haven't we been around each technology royalties in mutagenesis, even multiple crop that the with of X trait, their royalties and a at fact this traits. over scientists, Although technology Cibus rice X mastery model each X and platform.For has $X crops, platforms product have important third as system that close successful of rice, intellectual have many, Important property. canola we crop team developed, these accomplishment, trait, as built strong soybean. traits now crop fully platform, at are X to a the supporting and a being bigger field and years addition, the production platform to strong trials, is X well generate of for in Cibus customer has able base.In

In XXXX.Now up trait It our expect a platform which around been our X developed have these bulks point and years, to have the registration marketing process, at product development this ultimately process. its the Cibus.We dossier operational inventory, been we Our their initiates the strengthens in throughput paid with being are excited begin customer our prospects and seed active process farmers, very plan, Pod a has seeds the development canola about traits. soybean which are we results them now seed then back and trait. commercializing to weather seeds, accelerate commercialization our transfer the Shatter quickly, we've in timeline, their for be traits then editing edit proprietary confirmed, germ allowing plasm several its and them distributes and Once first the to Resistant QX X to the the for can crops soybean conditions. protects process, develops We to royalties that plasm platform consider extreme customer trait, PSR. the satisfied these through accelerating high execute this to we under very germ we customers' our

of germ XX Based plasm now shown [ have our with customers now We multiple ] leaked million crops we trials. XX these their that these trait. Canola have have have field PSR efficacy returning PSR's represent to WOSR.We started and field customers different we trials, edited acres in on estimate over

approximately for to important stated, never we we additional and and or be could additionally, increase HTX We annual tolerance This the Rice in customers. rice. are high royalties million herbicide market are utilize weed from management. the demand HTX GMO estimate canola, customers have remaining They is genetic traits. PSR, developed to annually.In X in X had $XXX soybean penetration we rice. As X complete transfer addition to our expect to XXXX currently and herbicide the transfers expect in trait PSR in that XXXX for customers corn management. traits these traits has traits traits and weed why XX% of Over GMO-based in are with

million customers the transferred HTX We over to in in for traits first have already we represent our We Nutrien and now American HTX, South believe have who the America. X market. North rice acres North X

similar million and traits are royalties HTX approximately HTX, fees customers year.These now America We annual expect trait South that in additional a the HG America fully XXXX. from could in be $XXX estimate North The We work and in we'll accelerated rice commercial lines validated has and of X in traits our in generate developed royalties streams. customers' progression be to to future XXXX. these progression will our significantly PSR, tracking the that

these multiple addition X adding canola X We customers They traits traits are across and to are developed look X the across over also soybean. they are our traits traits, on new potential both customers and you back types. to advanced our forward traits, are We efficacy of both meaning have and crop updating progress these to additional quarters.In preceding shipping crops the multi-crop critically important.

have trait the herbicides. action overuse management. advanced last resistant is Because modes extensive of certain first of many become HTX of the to herbicide-resistant XX The for those #X weeds over or weed years,

canola first soybean, herbicides new of soybean, associated weeds.That HTX.We and the we is crops and like target traits this broad for herbicide acres. greenhouse both and exceed XXX market expect Because there is [indiscernible] next demand summer that in the canola the extensive potential its for for be million important to it broad-spectrum has For leaf believe to demand trait results trait.

diseases For is industry for resistance. acres.The million utilized are Sclerotinia sclerotinia traits advanced the damaging impacting soybean. X the trait of in the on estimates herbicide over canola or based white perspective, XXX second is most that GMO and disease planted currently mold major

largest not a condition. mode the address of trait, successful traits single well deployed both that trait XXXX. is development and successful, of we and soybean, applicable progressed be the trait this date.The would the durable, this these this trait If that disease across disease in be the edited is to action If trait. has crops. As to be parts order gene needs will canola to first X this In of multiple this disease trait to have potential be to believe multiple major trait a

of payments profitability. our economic the will progression track their Over also customers, commercial these the a traits component and royalties X to their significant years, to and payments. These and their next of will be base advancement and we alliance traits royalties

will this of component our is a very trait, business We closely.Soybean follow on crop the quarterly plan. X last X basis progress

our significant have single soybean completing progress had cell We editing platform. in

complete will platform we believe this As XXXX. we we stated, in still have development FY of that

into each our of is to going central plasm to pillar our central platform, of discussions have customers, track the that, the progression by will our have we gene next strategy. in like track have significant X soybean the soybean updates growth for large germ Once we elite our to pass model the of to We of the few XXX We each intend major a agriculture.As expect crop corporate forward, X crops. we initial achieved going soybean on the quarterly over business. of each progression soybean I'd acre Over base and years, is to trait, is progression a believe America. be growth will just that editing of already generating and of remarks. date.This the our to be we and other Peter and companies combination had in million economic his contributor as plus trait central crop focus major South seed crop and of of royalties Many customers revenue.With North starts clear, forward is Cibus deployed will a are the our trait as call based

Peter Beetham

Rory Thank afternoon you everybody. good and to

Development are gene mentioned, of as that this differentiation that, agriculture's then to identical it, model allows of an technologies. moment. gene gene have edited in edit trait the trait, at acceleration with and key plasm. Rory and reduced the we digital germ germ customers' from scaling our at to plasm cell with Cibus is speed As development say scale genetics cells crops.The System, the elite expense the regenerated us really forefront companies.Our represent point This of is be into elite bringing best and focus edited significantly the genetics. are other plants the edits. of continues targeted X extracted because innovations to from the to these traits, crops fundamentally Trait germ We analog new seed We With a single elite editing changing edited time elite just that plasm X technologies Cibus' plant we trait The RTDS behind term industry. in Rapid from of

Once basis we works. shared it plasm, the machine to Here's an how the editing, in next trait of a germ plasm new Rory to a product new machine. we XX invest And simply to When high the when quarter, that a a we we set Instead, crop to culture rapid semi-automated we and in of secure physically high last developing just it to to the we mentioned, add experience, gene the facility development. be throughput scale edit new plant see months.It's don't editing approval we play efficiency note, product years them, to to editing portfolio, edit that new that the enters have new plug customers allows, from from solutions, our of their platform, trait automation as reagents. company is the our deliver we machine.As may opened design plasm any as begins, germ we and over facility. their our applying important for use add tissue aka first seed excited of we required.The receive the are simplicity trait changes And first entirely facilitate acceleration our at and the set gene in throughput while this additional transfers add our is relative XXXX. germ and

the to through is molecular it exception they make. the as investments quality the customers, the accelerate we at our to down XX between growth line truly so process.Cutting guidance to supply how for our lasting prior ensure confirmation years and edits to While on our genetics. and customers. to we our elite to editing of the to the to is identical margin, generate the the traits process in our early process Thank can to can seeds envision important process underpins over greenhouses critical helping CapEx long is to sole decade hand run business.Back and trait flowing assurance received, work been has trialing we rooms, revolutionary customers' been a many cash edit, what proceed the their completed we work historically that to a customers' provides is then with of business.When field Rory. early is begin completed for throughput is strategy the We and with developed our we high initially free build entire commercialization the and This back high of machine. has XX years absolutely small Once of that showcase we on quality our Cibus, We note high excellent our complete, This you. elite commercial few a germ months.It accelerate curtail a receive processed scaled, significant you process. have their edit what plasm, this efficiency we of trait, also validate customer, scale entering process

Rory Riggs

In to what for our key schedule we around important traits an summer traits. address.In and capabilities agriculture field applications of the in crop elements other crops, and model this canola X Peter. our and just trait, are market studies each in the to $X an beginning our commercialization opportunity a of commercialization and addressable time over in believe are The X there addition royalties, is trial year can are summary, rice, had major efforts. of crop we is our X are for advancing our trait Thanks that X commercialization X also extensive underway field well process, ultimately X efforts this represents billion soybean. with Combined, centered

conventional-like.The and various sclerotinia advance developed regulatory also and quarter, of be additional third network that partners we platform regime white the is many countries the reasons. EU without pipeline. to global we transgenes. sclerotinia our established the the development in This security. through X world.Most from of We network resistant to key trading Australia are efficacy Regulation to gene Bringing also is mold worked as fields, existing College of proposal, around be technology, the this years, climate products gene has action performance a agriculture, work gene been of NGTs highlights July launch EU the customers not of that conventional-like does Commission South New the with Genomic editing demonstrate action the our specifically In Commission use editing from introduction have and for NGT ] that the enabling first Under the recently, considered EU NGTs. in of identifies sustainable of resistance.XXXX Commissioners transgene America, closer new North use on multi-locational in the a referred often as proposal, use [ the to varieties. we food European products multiple testing on technology would for the of recent gene traits.Additionally, the contribute our adopted The together our proposed X, and of field proposal for that the regulation modes Japan.In potential of as year editing in to would obtained more to seen for of of a conventional and modes progressing field editing Cibus' policy regulated Techniques, resilience category critical in Plants important

rest First, it of bellwether for the critical is the a world.

rape has trait our million winter Europe, which Second, been there strategy.Our PSR in grown we other not it suitable for trials ties in of the developed And of access field have basis. market directly represents acres million to also The into our XXXX. acres traits over own trait approximately a are XX our in XXX are had progression that for for on technologies. technology third, is this the U.K. trait canola global GMO market pipeline.These advanced our in this within and major began and steps oilseed products

I'll the and as to for update monitor occur, gene on financials. technology but we're continue review regulatory to progress a on will these plant be call methodology on editing globally traits.Now to our for briefly We pass Wade to advancing target the approved they advances

Wade King

Rory. you Thank

awards.SG&A for for million The expense Looking XX, cash period. an XXXX and and September will cash enable the to our the of to filings quarter to stock-based for loss refer as period. remarks. XXXX, back quarter the the concludes for $XX.X million capital financial period.For equivalents at primarily our financials was in third quarter increase stock third was to consulting increase income to in million year compared for the million $X.X $XX.X XXXX. restricted fair common non-operating fund due cash of million to million XXXX. $X.X XXXX, was grants.Non-operating Rory, XXXX, in year of discussion. and details compensation liability an expenses the and legal was of compared your ago expense in of compared closing the equivalents the about ago XXXX, $X quarter; for third expense for requirements press to please headcount, related of period. you was headcount of the compared of decrease in and Class employee the ago and loss fees, with primarily $X.X year classified million for to R&D A a increased cash an warrants.Net We third expense The believe the quarter expenditure in expenses, stock our $XX.X additional of planned our stock restricted compensation an was our quarter stock-based was quarter in ago increase us net financials and and into million in first SEC.That the release operating expense third of the increased lab increase changes increase related to value $X.X $X year supply The for increase facility was in million to third

Rory Riggs

Thanks, deployment we I environment their opportunities really for point of enhance bring innovation how offerings to improved an food team our can't to our us shortages. as for farmer experienced tell With you where hungry trait the what Cibus. on to our the for solve tailwinds We industry Wade, plasm and executing elite regulatory historic ahead Cibus advance see first product the a you development, listening in. in customers' is the believe updating and to are are to rapid an We of we to from our we everyone breakthroughs inflection prepared that germ at at we that many the for traits the time, future to concludes that's thanks continue on to excited brings can, remarks. customer. their of look call.Operator, forward next benefit world's

now call up open may for Q&A. You the

Operator

[Operator Instructions] Bobby Burleson is And line our first the of from Canaccord. question from

Bobby Burleson

is just currently question So, efforts I around guess, to understand helping underway. us prioritize my some first the of how

we So, Maybe took significance market opportunity over if or just by progress announced or of place at commercialization addressable the quarter. rank look can help the total both? that in terms that that some you us of guys time line

Rory Riggs

Bobby, great that's question. a

realize traits. these our these really prioritize X And developed have We totally traits, prioritized. X they're you is

Latin we've already in because think done the America. signed plus get in some so, big what million rice we've what here in big customer, And demand along? Peter And or But last of X is to And it. X.X I'll emphasis quarter pod let the along? acres. of further which really the further shatter happened now the we we get happened in rice, represents talk And to saying, quarter minus work to last have

in of We have a number right target. others the

And us been the their the in the and germ process progress who customers. are are And germ development us has done in these customers our in plasm. so, we've putting now sending of traits their real commercial plasm

signing launch year in progress, you'll we're it with And able them follow so next so, hopefully, And this these acreage to the our is contracts is The these and to bulk goal is to they up take business to process. we plasms it. over the and their we're turn how get crops the goal so could be get traits germ the back in of with can launching germ go people's can to And plasms. fast they alone. it these and part plasms germ around

the interesting they So, on when good up I'd is, what's bulk about and first, shatter big to them the XX we'll field of the and customers a different we launching shatter time pod back. and is thing pretty field of in ship we traits pod studies germ able ability studies. do studies go.And and of the we've and the when like we're combination process But sense with that Peter pod plasm with talk back, about in they their when have have edited shatter, field really now we're a getting to their

more importantly, they time to that delayed, bit model things traits be and this and do these where want we have get to clear things, We for we're doing same but to about planting get for going little how ready each got them about all say able be But X around the we're encouraged why of for by a to are need things throw to really plants field revenues.Peter, to these time. of you the on be to one are to studies? tell ready you whether think and

Peter Beetham

the Thanks, and for question Bobby, I do. thanks, Rory.

on to and call, specifically about we midst I our XX back elite pod Rory in canola going of the and the have shatter in our as way and germ mentioned, I've transferring about think think I'm mentioned that, to progress, we're it whose to plasm talk is best genetics, hands that. customers the

to equates as we've transferred over lines our million X in acres The as So, elite accessing customer genetics so time. group XX back. in the whole of we far of that have much XXXX, hand

summer. to in exciting starting trials then pod the that that So looking really And And traits We're for XXXX. nurseries next see in the in evaluation is were winter with field level hybrids we'll transfers us in canola doing the be canola we're so in field are that, shatter this genetics. winter, occur. that successful at pre-commercialization excited last what's to move performance to and with customer this the them of very hybrids then traits

Rory Riggs

do we're so germ fact we're that that, model we really we on plasm, this X are we can't are address question? excited but suddenly doing once that soybeans. really that Bobby, single so it year. we'll in people excited then, be a these we that opportunity to focused just it's the lot big -- this the -- your other And There's that traits back and really able believe into X have business.Does crops. who ignore regenerates We're cell crops have about customers that we think big soybean X GDM the a plant just business. once And and We finish of this to build in in that a soybean, thing, this opportunity

Bobby Burleson

wondering, food been guess, these in acronyms, or that's Are guess, is I very there of something of with it's how coming other regulating in pulled Obviously, Is lots then, and works but from their regulations? I this are calling this food has kind And what for the I very helpful. Canada long to it? your system constrained great. a about between you they order of was time And kind this doing a NGTs, change aspects of treatment proposed re-evaluating being is parallel the wise where Yes, then of EU? what a talking security follow-up. EU some And I'm the what sounds just along ways, demand in that's they're in Yes, can they're and done? on regulatory draw draft already positive.

Rory Riggs

Peter, the take let let go and with specifics customers. me overview the to you

how customers The under try productivity the laws have the be we U.K. editing from a And GMOs Europe. gone we in been demand shock understand. fact consensus the to in treated Europe But the to do in The biggest helpful now as having our breeding. customers any gets transgenes have, them to across canola that the really not big there's it'd all. and so think gene so and I at X-year has process that we U.K. is for actual in down, studies include canola can doesn't conventional has their broad change

we they surprised this they and basically safe study, they And technology months was law. drew was, our so, -- when said it. probably their X this But was And what they need before we talked did us February. it happen. And press they -- our months about release, we X would when to press in We're we taking in June. it release, of said before thinking that the Parliament in thought safety

it in customers? want to Europe.Peter, the these the so passed pretty we're this, a process behind but add in might not you is to really they're forward to speed encouraging can up studies we us us. So it the there's helpful, if that you now having quite that's just U.K., -- for because do U.K. deal of excited grown field us.But, big go really, it's get allows progression, trying the Peter, are to And start the progression to an moment of products all that

Peter Beetham

Yes, exactly, Rory.

this I is trying point think, affairs. to EU is state accelerate that really Bobby, the which normal your of is the because question on it's around regulatory, clear this not

and very bring are excited to traits to number are Europe in a our market. with opportunity the so, customers based And of

security, a market the regulatory. that point acre improving drivers a hasn't is of agriculture, just Now, food lot climate last XX whole they XXX To and this is million -- of the big had about resilience years. are Europe the sustainable innovation a in for

exciting is are X oilseed mentioned agencies non-transgenic a I front your a them essentially have process think lot our you is rape.And -- XXXX. The spring That techniques, customers, to genetics where So ones and in our that winter like Canada step. regulatory have huge for new we a improved into for where product. they is, because first on onto call for harmonizing the really Cibus, and from of as in it's the of and products globally, but a is progress U.K., these on alignment by seen Europe the regulatory technology customers a the genomic see in question, and non-transgenic that seeing bring we the trials marketplace specifically edited over fact the products of -- tailwinds the winter canola, to gene

around the up someone So they're opens like harmonizing Cibus. markets world. that global really And for

Rory Riggs

And trade contract now. had the has of under already. neat to a million number think a And have have XXX ever. we customers X we about acres thing wheat this is And never

So us. opportunity didn't I the instructions. a it's big I'm get sorry. for

Bobby Burleson

to And that's a this EU. the No, additional great cover imports also would color. into clear, be

Rory Riggs

breeding Yes. into Europe. trait, That you when these a means laws The it is to it that, correct. are, develop once we coming like will treated conventional key do be

familiar GMO aren't new with everything we to to for big But get We'll years products drugs. that export be the takes Europe think clear for it's have suddenly almost it, big And trait... approval. industry. X approval. develop moment It soybean. going I will who moment will like a be a people introduce X For treats to It

Bobby Burleson

Yes, understood.

you're there significant So, at yes, as some at introduce lower of this potentially looking trait is the these GM germ of could what where maybe a part a over be just GM stacked can cost just And technology, you be and simply which on where is time? there interest doing existing plasm, you'll huge. in speed of because seeds at the

Rory Riggs

is, not don't that's real matter And traits. one they about has It the But that have all shatter, The totally is. developed team of speed. fact that's pod trait. our actually

we plasm the cell a Peter figured us So real And take to plasm trait and that's traits. in Peter, it send think edit that? want the from if it, -- how out in to trials.And do the thing to if field now germ germ XX that plasm XX speed that, grow plasm, that's... months, in you your single actually to our can you to germ is, canola, fact add first have germ and your then is us literally there's that have ready Greg your send I you that part that

Bobby Burleson

where pretty seems about edited It tempted important market's much an bigger, is that's right? technology this relevance. think all has talking Because purely be to like we're much seeds. Because people the right? seeds distinction, your But might gene

Peter Beetham

Yes.

add really in, I point. a on you because me Bobby, Let important hit think

limitations major limitations It's Bringing that, the is is could my gene on Windows for For are bringing us in XX GMO, forward like just old valuable edited in who forward do. that it's have you market. technology. really been very is what In mind the tech XX. years, over there traits traits recognition to

where barrier North traits So going complete been and South that markets with traits. to where where gene already has editing. genetics we be getting there's adding in more it, GMOs clear be free And have other we'll where then there's there you're a can in, and markets, to access to perhaps America, global markets,

traits opportunity in Plus like the is mold, like resistance, so, expansion could that's the white technologies serotonin, can gene huge. that, past. editing And other disease the is not where address -- and fact

be So open it's never using opportunities to were that -- not up other traits able and only does done global it opens up it markets, technologies.

Bobby Burleson

that's I'm let a or X a question going here. realize Because ask X to in I somebody else row.

Rory Riggs

But, Peter, big India? while tell can soybean he's them for about is marketplace rice. and breaking, you India a both such

Peter Beetham

Yes.

need what seeded they That's can has is market, a market, really I it it's direct but like think just XXX tolerance that's is of they India. in very of for something that -- And million traits. market are rice. India Bayer call has of rice. recently -- you around, which is seeded appetite to released huge where targeting do able million XX so a XX% direct herbicide an trait that nearly fragmented just to a be And acres example acres

not opening an there's up So for the but markets traits. better appetite, genetics, to also genetics only with

take in traits but well different what's relative. North the different as an bit as India genetics agriculture America, very a is it than classic India example canola. is market on than So a a emerging will in rice, close It's little in of that in

Operator

Jefferies. from with of Alexander is the question next Laurence line our And

Kevin Estok

Estok for This Laurence. is on Kevin

for me. X Just question

has volatility partnerships what year? in the milestones timetable your what or extent for market, -- has to yes, Just so extent the I our from research the guess, and distracted customers next volatility ag change

Rory Riggs

much. traits not focused decrease, research leave on give news are see focus we answer? that to actually out people The we're little already a trying it that actual see good trying that Peter more traits to, we're want to as you we the have of on can bit we but developed, volatility to on haven't develop increase new And we have we're there really agreements and want because what and I'll We I'll is they right? the go where buy.Peter, to that, sell to can seen markets.

Peter Beetham

the there, volatility I No, sure. think is for

role traits I for productivity. increasing farmers' industry is a think play seed the where in

by they the so, they deliver that And increasing appetite in see have for demand farmers can genetics because our is to like for traits we increasing, additional productivity. traits better profits their customers so from our would that of

volatility is my demand like seed requirements technologies accelerates for actually, the the in to the delivering customers. So, Cibus and mind,

Rory Riggs

between stuff, right? It and strict of aspects is which been productivity traits interesting, stuff the I Specific think. yield distinction has specific a trait

Operator

questions you call will to at And there closing the for now I Mr. no this are back Riggs, remarks. time. further turn

Rory Riggs

thanks questions. Tim, Thanks, for and the

I these calls the now goal help understand think you that in to our is progression.

to field because well this quarter, aspects there our like every of actual the the of in have that, be study traits. every this accessed quarter we be goal how We towards being track And was will able quarter, having by field farmers. to are

big And things the are: moment our that's really us. mapping think big do is, see just get be the off? a X, to that seems soybean progression, it we Because things so, X, for value can X we've going besides And accelerating. about talked to everybody's Europe and I

we're important of global. our sort as suddenly and X And quick as trait model, And understanding truly the excited so, it. by X And get most crop, behind can Europe is part become and we us, we a become following real we it. progression business just really

a exciting that's you please anything, good... be If It's to any call. questions, track.Peter, able to really or for moment want have a us you I to guys add think more

Peter Beetham

inflection summation, think a Cool Rory. Definitely where are. I that's we point for good an

Rory Riggs

Thanks, guys. Thanks, Tim.

done. we're think I

Operator

We does lines. your thank please call you conference for today. your participation that you That ask conclude for your disconnect and

Cibus (CBUS) 9 Nov 232023 Q3 Earnings call transcript